Equity · Healthcare
LLY
NYSEEli Lilly and Company (LLY)
The line runs 1,230 USD on 10 August through 1,354 USD on 6 November, on a scale from 1,100 to 1,500. Days the market did not trade hold the previous close, flat.
- Market cap
- 1.27T USD
- P/E (TTM)
- 44.0
- Revenue, year to Dec 2025
- 65.2B USD
- EPS, diluted, year to Dec 2025
- 22.95 USD
- 52-week range
- 845 USD – 1,418.07 USD
- Avg volume
- 128.7K
- Mentions, 30 days
- 189
- Net sentiment
- +0.13
as of Nov 6, 2026
Have Eli Lilly and Company (LLY) insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, Eli Lilly and Company insiders reported 3 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 7 Jan 2026, show no open-market purchase.
Form 4, 90 days to 9 Nov 2026, newest reported trade 2 Nov 2026
Buys 0Sells 3Net sold $17.02MOther filings 27
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Nov 2026 | Hakim AnatEVP, GC & Secretary | Sell | 5,000 | 7.0M USD |
| 17 Aug 2026 | Jonsson PatrikEVP & President, LLY Int'l | Sell | 6,500 | 7.6M USD |
| 10 Aug 2026 | Zakrowski Donald ASVP, Finance, & CAO | Sell | 2,000 | 2.4M USD |
| Sold | 3 open-market sales | 13,500 | $17.02M |
27 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 03 Nov 2026 | Ricks David APresident, Chair, and CEO | Gift | 23,538 | |
| 02 Nov 2026 | Skovronsky DanielEVP, CS&PO & Pres. LRL | Gift | 119 | |
| 01 Nov 2026 | Brown Adrienne SEVP, President LLY Imm | Option exercise | 2,530 | |
| 01 Nov 2026 | Brown Adrienne SEVP, President LLY Imm | Tax withheld | 1,099 | 1.6M USD |
| 01 Nov 2026 | Custer Kenneth L.EVP & President, Card Met Hlth | Option exercise | 3,220 | |
| 01 Nov 2026 | Custer Kenneth L.EVP & President, Card Met Hlth | Tax withheld | 1,425 | 2.0M USD |
| 01 Nov 2026 | Dozier EricEVP, Chief People Officer | Option exercise | 2,300 | |
| 01 Nov 2026 | Dozier EricEVP, Chief People Officer | Tax withheld | 1,019 | 1.4M USD |
| 01 Nov 2026 | Montarce LucasEVP & CFO | Option exercise | 1,610 | |
| 01 Nov 2026 | Montarce LucasEVP & CFO | Tax withheld | 678 | 961K USD |
| 01 Nov 2026 | Hernandez EdgardoEVP & Pres., Mfg. Operations | Option exercise | 2,530 | |
| 01 Nov 2026 | Hernandez EdgardoEVP & Pres., Mfg. Operations | Tax withheld | 1,123 | 1.6M USD |
Showing the 12 most recent of 27 compensation filings in this window. The figures above count all of them.
Which funds hold Eli Lilly and Company (LLY)?
1 of the 45 institutional funds we track reported a Eli Lilly and Company position for the quarter ended 30 Sep 2026 — a combined 6.3B USD; the latest of those filings landed 06 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 5,424,027 | 6.3B USD | +7.1% |
Have members of Congress traded Eli Lilly and Company (LLY)?
The most recent congressional trade disclosed in Eli Lilly and Company is a sale by Michael A. Rulli (house, OH), dated 01 Jul 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 01 Jul 2026 | Michael A. Rullihouse · Republican–OH | Sale | 1K USD–15K USD | 37 days |
| 10 Jun 2026 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | 50K USD–100K USD | 22 days |
| 14 Apr 2026 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | 1K USD–15K USD | 24 days |
| 02 Apr 2026 | Byron Donaldshouse · Republican–FL | Purchase | 1K USD–15K USD | 41 days |
| 26 Feb 2026 | David J. Taylorhouse · Republican–OH | Purchase | 1K USD–15K USD | 8 days |
| 09 Feb 2026 | David J. Taylorhouse · Republican–OH | Sale | 1K USD–15K USD | 11 days |
| 18 Dec 2025 | Julie Johnsonhouse · Democrat–TX | Sale | 1K USD–15K USD | 28 days |
| 10 Dec 2025 | David J. Taylorhouse · Republican–OH | Sale | 1K USD–15K USD | 9 days |
What has been filed or recorded for Eli Lilly and Company (LLY)?
The filings we hold for Eli Lilly and Company, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 4,130 shares | 4.9M USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 135 shares | 158K USD notional · <0.001% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 12 shares | 14K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 7.22 USD | Revenue $24.40B |
| 30 Sep 2026 | Financials | Total assets | 148.1B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 40.3B USD | at period end |
| 24 Sep 2026 | Fails to deliver | Shares failed to deliver | 308 shares | 355K USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 7.94 USD | Revenue $22.97B |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 8.26 USD | Revenue $19.80B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 22.95 USD | Revenue $65.18B |
| 31 Dec 2025 | Financials | Revenue | 65.2B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 20.6B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 22.95 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 6.21 USD | Revenue $17.60B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 6.29 USD | Revenue $15.56B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 3.06 USD | Revenue $12.73B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 11.71 USD | Revenue $45.04B |
What is Reddit saying about Eli Lilly and Company (LLY)?
Reddit mentioned LLY 189 times in the 30 days to 8 November 2026, across 6 of the communities we track. All of them were scored for sentiment: 73% read bullish, 7% bearish and 20% neither. Reddit data updated 8 November 2026.
30-day window, Method
Mentions, 30 days 189Bullish 73%Bearish 7%Communities 6Against the market +19 points
How do Reddit mentions of Eli Lilly and Company (LLY) compare with its price?
Share ↗
Is the Reddit crowd more bullish on Eli Lilly and Company than on the market?
LLY reads 64% bullish, 10 points above the market (54%). Over 90 days the gap has run from -1 to +37 points.
- LLY
- 64%
- bullish, 8 Nov
- Market
- 54%
- bullish, all Reddit, 8 Nov
- Gap
- +10 pts
- LLY against market
Where Eli Lilly and Company (LLY) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 72% | 136 | +0.12 |
| r/stocks | 17% | 33 | +0.17 |
| r/investing | 5% | 10 | +0.14 |
| r/etfs | 4% | 7 | +0.20 |
| r/ausfinance | 1% | 2 | +0.00 |
| r/options | 1% | 1 | +0.24 |
Moves with Eli Lilly and Company (LLY)
Tickers whose daily Reddit volume rose and fell with Eli Lilly and Company (LLY)'s. Co-discussion, not price.
RDDT +0.89INTC +0.88PC +0.86AMZN +0.85BNB.X +0.81BINANCE.PRV +0.76
How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method
Eli Lilly and Company (LLY): frequently asked questions
What did Eli Lilly and Company shares close at?
Eli Lilly and Company closed at 1,354.00 USD on 6 Nov 2026, down 0.81% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Eli Lilly and Company’s market cap?
Eli Lilly and Company is worth 1.27T USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Eli Lilly and Company’s P/E ratio?
Eli Lilly and Company has a price-to-earnings ratio of 44.0, as of 6 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Eli Lilly and Company’s revenue?
Eli Lilly and Company reported revenue of 65.2B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Eli Lilly and Company insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, Eli Lilly and Company insiders reported 3 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 7 Jan 2026, show no open-market purchase. A further 27 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Eli Lilly and Company?
1 of the 45 funds we track reported a Eli Lilly and Company position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds
Have members of Congress traded Eli Lilly and Company?
Yes. 95 trades in Eli Lilly and Company appear in the congressional disclosures we hold; the latest is a sale by Michael A. Rulli (House, OH) dated 1 Jul 2026, filed 7 Aug 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Eli Lilly and Company last report earnings?
Eli Lilly and Company last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 7.22 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Eli Lilly and Company?
Eli Lilly and Company was mentioned 36 times in the last 7 days across the finance subreddits we track, and 189 times over the trailing 30 days. Of the 189 mentions scored for sentiment, 73% read bullish and 7% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings